ArticleDrug design, development and therapy2021

Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China.

Xingbing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.